Skip to content

Opening book details…

About this Medicine article

Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma: report of a phase II trial by Neri, B.; Cipriani, G.; Fulignati, C.; Turrini, M.; Ponchietti, R.; Bartoletti, R.; Della Melina, A.; Di Cello, V.; Dominici, A.; Maleci, D.; Raugei, A.; Villari, D.; Nicita, G. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Neri, B.; Cipriani, G.; Fulignati, C.; Turrini, M.; Ponchietti, R.; Bartoletti, R.; Della Melina, A.; Di Cello, V.; Dominici, A.; Maleci, D.; Raugei, A.; Villari, D.; Nicita, G.
Publisher
Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0959-4973)
Published
2005
Language
EN
Field
Medicine (Health Sciences)

More by Neri, B.; Cipriani, G.; Fulignati, C.; Turrini, M.; Ponchietti, R.; Bartoletti, R.; Della Melina, A.; Di Cello, V.; Dominici, A.; Maleci, D.; Raugei, A.; Villari, D.; Nicita, G.

Browse all works by Neri, B.; Cipriani, G.; Fulignati, C.; Turrini, M.; Ponchietti, R.; Bartoletti, R.; Della Melina, A.; Di Cello, V.; Dominici, A.; Maleci, D.; Raugei, A.; Villari, D.; Nicita, G.